TMS may be helpful as an off-label treatment. Many clinical studies have been performed that support such treatments, but TMS is not yet approved by the FDA to treat disorders beyond depression and OCD. For off-label treatments, the TMS device is set to different parameters in order to trigger appropriate and beneficial responses in the brain. In Europe, the CE (European equivalent of the FDA in the US) approved TMS to treat depression, OCD, bipolar depression, PTSD, Alzheimer’s disease, chronic pain, addiction, depression with anxiety, and smoking cessation.
TMS is a safe and effective alternative to medications that does not use anesthesia or have long-term side effects. To learn if you’re a candidate for TMS treatment, call the TMS Institute at 480-448-2916 to schedule a detailed evaluation.